Tecan Group AG

SWX:TECN Stock Report

Market Cap: CHF 1.9b

Tecan Group Past Earnings Performance

Past criteria checks 0/6

Tecan Group's earnings have been declining at an average annual rate of -25.5%, while the Life Sciences industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 0.9% per year.

Key information

-25.46%

Earnings growth rate

-26.64%

EPS growth rate

Life Sciences Industry Growth17.57%
Revenue growth rate0.88%
Return on equity-9.61%
Net Margin-12.54%
Next Earnings Update11 Aug 2026

Recent past performance updates

Analysis Article Aug 20

Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...

Recent updates

Narrative Update Jun 14

TECN: Reset CHF 205 Goal Will Support Future Earnings Re Rating

Analysts have reduced their price target for Tecan Group from CHF 335.08 to CHF 205.00, citing updated assumptions for revenue growth, profit margins and future P/E multiples, along with recent Street research cuts from CHF 10 and CHF 1. Analyst Commentary Recent Street research has focused on recalibrating Tecan Group’s valuation framework, with price targets adjusted to reflect updated views on revenue growth, margins and P/E multiples.
Narrative Update May 31

TECN: Reduced P/E Expectations Will Limit Perceived Upside Potential

Analysts have trimmed their price targets on Tecan Group by CHF 1 to CHF 10 in recent updates. This reflects revised assumptions around discount rates, profit margins and future P/E expectations.
Narrative Update May 02

TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential

Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.
Narrative Update Apr 18

TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings

The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.
Narrative Update Apr 03

TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations

Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.
Narrative Update Mar 20

TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings

The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.
Narrative Update Mar 05

TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations

Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.
Narrative Update Feb 19

TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E

Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.
Narrative Update Feb 05

TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential

Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.
Narrative Update Jan 22

TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside

Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.
Narrative Update Jan 08

TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings

Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.
Analysis Article Dec 23

Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Narrative Update Dec 14

TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential

Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.
Narrative Update Nov 30

TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements

Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.
Narrative Update Nov 16

TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026

Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.
Analysis Article Nov 06

Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price

Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...
Narrative Update Nov 01

TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value

The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.
Analysis Article Oct 22

Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?

Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...
Narrative Update Oct 18

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.
Narrative Update Oct 04

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.
Narrative Update Sep 05

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.
Analysis Article Sep 04

Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Aug 20

Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...
Analysis Article Aug 08

Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price

Key Insights Tecan Group's estimated fair value is CHF281 based on 2 Stage Free Cash Flow to Equity Current share price...
Analysis Article Jul 21

Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...
Analysis Article May 28

At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

While Tecan Group AG ( VTX:TECN ) might not have the largest market cap around , it saw a significant share price rise...
Analysis Article Apr 24

Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?

Key Insights Tecan Group's estimated fair value is CHF199 based on 2 Stage Free Cash Flow to Equity Tecan Group is...
Analysis Article Apr 08

Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

To the annoyance of some shareholders, Tecan Group AG ( VTX:TECN ) shares are down a considerable 25% in the last...
Analysis Article Apr 04

Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely

Key Insights Tecan Group will host its Annual General Meeting on 10th of April Total pay for CEO Achim von Leoprechting...
Analysis Article Apr 01

Is Tecan Group (VTX:TECN) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
User avatar
New Narrative Mar 16

Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production

Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.
Analysis Article Jan 12

Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...
Analysis Article Dec 21

A Look At The Fair Value Of Tecan Group AG (VTX:TECN)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF231 With CHF198 share...
Analysis Article Oct 09

Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable

With a price-to-earnings (or "P/E") ratio of 33.7x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...
Analysis Article Sep 21

These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Aug 16

Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%

It's been a sad week for Tecan Group AG ( VTX:TECN ), who've watched their investment drop 13% to CHF280 in the week...
Analysis Article Jun 14

Is Tecan Group (VTX:TECN) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article Apr 20

Calculating The Fair Value Of Tecan Group AG (VTX:TECN)

Key Insights Tecan Group's estimated fair value is CHF409 based on 2 Stage Free Cash Flow to Equity Current share price...

Revenue & Expenses Breakdown

How Tecan Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SWX:TECN Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 25882-11120067
30 Sep 25895-2419166
30 Jun 259076318271
31 Mar 259206518370
31 Dec 249346818463
30 Sep 249678518863
30 Jun 241,00010119264
31 Mar 241,03711719267
31 Dec 231,07413219270
30 Sep 231,08812019874
30 Jun 231,10210920578
31 Mar 231,12311520978
31 Dec 221,14412121478
30 Sep 221,11011321279
30 Jun 221,07710521079
31 Mar 221,01211320176
31 Dec 2194712219272
30 Sep 2191113619270
30 Jun 2187515019168
31 Mar 2180312718265
31 Dec 2073110417262
30 Sep 206919416059
30 Jun 206518414956
31 Mar 206447914958
31 Dec 196377314960
30 Sep 196277015059
30 Jun 196166715159
31 Mar 196056914655
31 Dec 185947114151
30 Sep 185827013950
30 Jun 185706913849
31 Mar 185596713750
31 Dec 175496613650
30 Sep 175366213249
30 Jun 175235712948
31 Mar 175155612747
31 Dec 165065512547
30 Sep 164915512345
30 Jun 164765512043
31 Mar 164585611541
31 Dec 154405711040
30 Sep 154345210841
30 Jun 154274810642

Quality Earnings: TECN is currently unprofitable.

Growing Profit Margin: TECN is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TECN is unprofitable, and losses have increased over the past 5 years at a rate of 25.5% per year.

Accelerating Growth: Unable to compare TECN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TECN is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (5.4%).


Return on Equity

High ROE: TECN has a negative Return on Equity (-9.61%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/16 17:47
End of Day Share Price 2026/06/16 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tecan Group AG is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harry GillisBerenberg
Delphine Le LouetBernstein
Susannah LudwigBernstein